comparemela.com

Latest Breaking News On - Bioconnect conference - Page 23 : comparemela.com

Osmotica Pharmaceuticals plc to Present at H C Wainwright Bioconnect Conference

Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H C Wainwright BioConnect Conference

RenovaCare to Present at H C Wainwright BioConnect 2021 Conference

RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference ROSELAND, N.J., Jan. 08, 2021 RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Company will present at the 2021 H.C. Wainwright BioConnect Conference, scheduled for January 11 – 14. RenovaCare will be presenting information on its patented CellMist™ and SkinGun™ technologies to conference attendees including buy- and sell-side research teams. The presentation will be made available via an on-demand webcast to all registered conference attendees, including institutional investors, industry executives, and private equity firms, among others.

Achieve Life Sciences to Present at H C Wainwright Virtual BioConnect Conference

Achieve Life Sciences to Present at H C Wainwright Virtual BioConnect Conference
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Achieve Life Sciences, Inc : Achieve Life Sciences to Present at H C Wainwright Virtual BioConnect Conference

Achieve Life Sciences, Inc.: Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that John Bencich, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Conference being held virtually January 11-14, 2021. A webcast of the presentation will be available on Monday, January 11 th at 6:00 AM EST and can be accessed by visiting the Achieve Investor Relations page http://ir.achievelifesciences.com/events-and-webcasts. About Achieve and Cytisinicline

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.